116 related articles for article (PubMed ID: 28105163)
1. Selection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptin.
Nemudraya AA; Kuligina EV; Ilyichev AA; Fomin AS; Stepanov GA; Savelyeva AV; Koval OA; Richter VA
Oncol Lett; 2016 Dec; 12(6):4547-4555. PubMed ID: 28105163
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin.
Nemudraya AA; Makartsova AA; Fomin AS; Nushtaeva AA; Koval OA; Richter VA; Kuligina EV
PLoS One; 2016; 11(8):e0160980. PubMed ID: 27513518
[TBL] [Abstract][Full Text] [Related]
3. Lactaptin induces p53-independent cell death associated with features of apoptosis and autophagy and delays growth of breast cancer cells in mouse xenografts.
Koval OA; Tkachenko AV; Fomin AS; Semenov DV; Nushtaeva AA; Kuligina EV; Zavjalov EL; Richter VA
PLoS One; 2014; 9(4):e93921. PubMed ID: 24710119
[TBL] [Abstract][Full Text] [Related]
4. A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice models.
Koval OA; Fomin AS; Kaledin VI; Semenov DV; Potapenko MO; Kuligina EV; Nikolin VP; Nikitenko EV; Richter VA
Biochimie; 2012 Dec; 94(12):2467-74. PubMed ID: 22968174
[TBL] [Abstract][Full Text] [Related]
5. Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin.
Chinak O; Golubitskaya E; Pyshnaya I; Stepanov G; Zhuravlev E; Richter V; Koval O
Front Pharmacol; 2019; 10():1043. PubMed ID: 31619993
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors.
Bagamanshina AV; Troitskaya OS; Nushtaeva AA; Yunusova AY; Starykovych MO; Kuligina EV; Kit YY; Richter M; Wohlfromm F; Kähne T; Lavrik IN; Richter VA; Koval OA
Biomed Res Int; 2019; 2019():4087160. PubMed ID: 31317028
[TBL] [Abstract][Full Text] [Related]
7. Recombinant analogs of a novel milk pro-apoptotic peptide, lactaptin, and their effect on cultured human cells.
Semenov DV; Fomin AS; Kuligina EV; Koval OA; Matveeva VA; Babkina IN; Tikunova NV; Richter VA
Protein J; 2010 Apr; 29(3):174-80. PubMed ID: 20232123
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Lactaptin Induces Immunogenic Cell Death and Creates an Antitumor Vaccination Effect in Vivo with Enhancement by an IDO Inhibitor.
Troitskaya O; Varlamov M; Nushtaeva A; Richter V; Koval O
Molecules; 2020 Jun; 25(12):. PubMed ID: 32560527
[TBL] [Abstract][Full Text] [Related]
9. The purification and identification of human blood serum proteins with affinity to the antitumor active RL2 lactaptin using magnetic microparticles.
Manko N; Starykovych M; Bobak Y; Stoika R; Richter V; Koval O; Lavrik I; Horák D; Souchelnytskyi S; Kit Y
Biomed Chromatogr; 2019 Nov; 33(11):e4647. PubMed ID: 31299101
[TBL] [Abstract][Full Text] [Related]
10. [Immunogenicity of recombinant analog of antitumor protein lactaptin].
Tkachenko AV; Troitskaya OS; Semenov DV; Dmitrienko EV; Kuligina EV; Richter VA; Koval OA
Mol Biol (Mosk); 2017; 51(5):787-796. PubMed ID: 29116065
[TBL] [Abstract][Full Text] [Related]
11. [The analysis of biochemical markers of MCF-7 cells apoptosis induced by recombinant analog of lactaptin].
Fomin AS; Koval' OA; Semenov DV; Potapenko MO; Kuligina EV; Kit IuIa; Rikhter VA
Bioorg Khim; 2012; 38(1):92-8. PubMed ID: 22792711
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of endometrial cancer cells from primary human tumor samples to new potential anticancer peptide lactaptin.
Koval OA; Sakaeva GR; Fomin AS; Nushtaeva AA; Semenov DV; Kuligina EV; Gulyaeva LF; Gerasimov AV; Richter VA
J Cancer Res Ther; 2015; 11(2):345-51. PubMed ID: 26148598
[TBL] [Abstract][Full Text] [Related]
13. Structural and Aggregation Features of a Human κ-Casein Fragment with Antitumor and Cell-Penetrating Properties.
Chinak OA; Shernyukov AV; Ovcherenko SS; Sviridov EA; Golyshev VM; Fomin AS; Pyshnaya IA; Kuligina EV; Richter VA; Bagryanskaya EG
Molecules; 2019 Aug; 24(16):. PubMed ID: 31408975
[TBL] [Abstract][Full Text] [Related]
14. RL2 Enhances the Elimination of Breast Cancer Cells by Doxorubicin.
Wohlfromm F; Seyrek K; Ivanisenko N; Troitskaya O; Kulms D; Richter V; Koval O; Lavrik IN
Cells; 2023 Dec; 12(24):. PubMed ID: 38132099
[TBL] [Abstract][Full Text] [Related]
15. Antimetastatic Effect of Liposomal Recombinant Lactaptin.
Kaledin VI; Koval OA; Kuligina EV; Lushnikova EL; Nikolin VP; Popova NA; Pyshnaya IA; Richter VA
Bull Exp Biol Med; 2018 Apr; 164(6):762-765. PubMed ID: 29666965
[TBL] [Abstract][Full Text] [Related]
16. The Recombinant Fragment of Human κ-Casein Induces Cell Death by Targeting the Proteins of Mitochondrial Import in Breast Cancer Cells.
Richter M; Wohlfromm F; Kähne T; Bongartz H; Seyrek K; Kit Y; Chinak O; Richter VA; Koval OA; Lavrik IN
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486420
[TBL] [Abstract][Full Text] [Related]
17. Interplay Between Mitophagy and Apoptosis Defines a Cell Fate Upon Co-treatment of Breast Cancer Cells With a Recombinant Fragment of Human κ-Casein and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand.
Wohlfromm F; Richter M; Otrin L; Seyrek K; Vidaković-Koch T; Kuligina E; Richter V; Koval O; Lavrik IN
Front Cell Dev Biol; 2020; 8():617762. PubMed ID: 33537307
[TBL] [Abstract][Full Text] [Related]
18. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
Kochneva G; Sivolobova G; Tkacheva A; Grazhdantseva A; Troitskaya O; Nushtaeva A; Tkachenko A; Kuligina E; Richter V; Koval O
Oncotarget; 2016 Nov; 7(45):74171-74188. PubMed ID: 27708236
[TBL] [Abstract][Full Text] [Related]
19. A novel vascular-targeting peptide for gastric cancer delivers low-dose TNFα to normalize the blood vessels and improve the anti-cancer efficiency of 5-fluorouracil.
Lu L; Li ZJ; Li LF; Shen J; Zhang L; Li MX; Xiao ZG; Wang JH; Cho CH
Peptides; 2017 Nov; 97():54-63. PubMed ID: 28970092
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting and microenvironment-responsive multifunctional fusion protein for pro-apoptotic peptide delivery.
Yin J; Liu D; Bao L; Wang Q; Chen Y; Hou S; Yue Y; Yao W; Gao X
Cancer Lett; 2019 Jun; 452():38-50. PubMed ID: 30904618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]